We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Illumina Inc | NASDAQ:ILMN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.53 | -0.49% | 108.00 | 107.65 | 109.87 | 108.30 | 106.82 | 108.00 | 1,715,382 | 01:00:00 |
From May 2023 to May 2024
By Will Feuer
Shares of Illumina slid more than 4% after the gene-sequencing company disclosed that the Securities and Exchange Commission is investigating the company's $7 billion takeover of cancer-test developer Grail.
The company said in a securities filing late Thursday that SEC staff in July requested documents and communications related to Illumina's buyout of Grail. The regulators also requested certain statements and disclosures concerning Grail, its products and the acquisition, as well as the conduct and compensation of certain members of Illumina and Grail management, among other things.
Illumina said it is cooperating with the investigation.
The stock fell 4.3% to $177.19 in midday trading. So far this year, shares have fallen more than 12%.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
August 11, 2023 13:17 ET (17:17 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Illumina Chart |
1 Month Illumina Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
